Your browser doesn't support javascript.
loading
Evaluation of the telehealth making sense of brain tumor psychological support intervention for people with primary brain tumor and their caregivers: A randomized controlled trial.
Ownsworth, Tamara; Chambers, Suzanne; Jones, Stephanie; Parker, Giverny; Aitken, Joanne F; Foote, Matthew; Gordon, Louisa G; Shum, David H K; Robertson, Julia; Conlon, Elizabeth; Pinkham, Mark B.
Affiliation
  • Ownsworth T; School of Applied Psychology, Griffith University, Brisbane, Queensland, Australia.
  • Chambers S; The Hopkins Centre, Menzies Health Institute of Queensland, Griffith University, Brisbane, Queensland, Australia.
  • Jones S; Faculty of Health Sciences, Australian Catholic University, Brisbane, Australia.
  • Parker G; School of Applied Psychology, Griffith University, Brisbane, Queensland, Australia.
  • Aitken JF; School of Applied Psychology, Griffith University, Brisbane, Queensland, Australia.
  • Foote M; Cancer Council Queensland, Brisbane, Queensland, Australia.
  • Gordon LG; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Shum DHK; School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Robertson J; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Conlon E; Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong, China.
  • Pinkham MB; Summer Foundation Ltd, Melbourne, Victoria, Australia.
Psychooncology ; 32(9): 1385-1394, 2023 09.
Article in En | MEDLINE | ID: mdl-37409906
ABSTRACT

OBJECTIVE:

This pragmatic randomized control trial aimed to evaluate clinical efficacy of the Making Sense of Brain Tumour program delivered via videoconferencing (Tele-MAST) for improving mental health and quality of life (QoL) relative to standard care in individuals with primary brain tumor (PBT).

METHOD:

Adults with PBT experiencing at least mild distress (Distress Thermometer ≥4) and caregivers were randomly allocated to the 10-session Tele-MAST program or standard care. Mental health and QoL were assessed pre-intervention, post-intervention (primary endpoint), and 6-weeks and 6-months follow-up. The primary outcome was clinician-rated depressive symptoms on the Montgomery-Asberg Depression Rating Scale.

RESULTS:

82 participants with PBT (34% benign, 20% lower-grade glioma, 46% high-grade glioma) and 36 caregivers were recruited (2018-2021). Controlling for baseline functioning, Tele-MAST participants with PBT had lower depressive symptoms at post-intervention (95% CI 10.2-14.6, vs. 15.2-19.6, p = 0.002) and 6-weeks post-intervention (95% CI 11.5-15.8 vs. 15.6-19.9, p = 0.010) than standard care, and were almost 4 times more likely to experience clinically reduced depression (OR, 3.89; 95% CI 1.5-9.9). Tele-MAST participants with PBT also reported significantly better global QoL, emotional QoL and lower anxiety at post-intervention and 6-weeks post-intervention than standard care. There were no significant intervention effects for caregivers. At 6-months follow-up participants with PBT who received Tele-MAST reported significantly better mental health and QoL relative to pre-intervention.

CONCLUSIONS:

Tele-MAST was found to be more effective for reducing depressive symptoms at post-intervention than standard care for people with PBT but not caregivers. Tailored and extended psychological support may be beneficial for people with PBT.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Telemedicine / Glioma Type of study: Clinical_trials Limits: Adult / Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Telemedicine / Glioma Type of study: Clinical_trials Limits: Adult / Humans Language: En Year: 2023 Type: Article